ASH2023注目テーマ③「Late-Breaking Abstracts Session #4」

重症の鎌状赤血球症に対するハプロ移植
HLA一致の骨髄移植と2年EFSは同等 Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507 (#LBA-4)

Adetola A. Kassim（Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, USA）